(Q54704721)

3 June 2018

title

Chronic inhibition of the high-affinity dopamine uptake system increases oxidative damage to proteins in the aged rat substantia nigra. (English)

1 reference

3 June 2018

1 reference

Romero-Ramos M

1

1 reference

3 June 2018

Rodríguez-Gómez JA

2

1 reference

3 June 2018

Venero JL

3

1 reference

3 June 2018

Cano J

4

1 reference

3 June 2018

Machado A

5

1 reference

3 June 2018

publication date

1 January 1997

1 reference

3 June 2018

Free Radical Biology and Medicine

published in

1 reference

3 June 2018

volume

23

1 reference

3 June 2018

issue

1

1 reference

3 June 2018

page(s)

1-7

1 reference

3 June 2018

Oxidative inactivation of tyrosine hydroxylase in substantia nigra of aged rat

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900405-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900405-4

1 reference

7 January 2021

Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900405-4

7 January 2021

Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease: a longterm study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900405-4

7 January 2021

(−)Deprenyl and (−)parafluorodeprenyl-treatment prevents age-related pigment changes in the substantia nigra. A TV-image analysis of neuromelanin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900405-4

7 January 2021

Deprenyl suppresses the oxidant stress associated with increased dopamine turnover

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900405-4

7 January 2021

Chronic L-deprenyl or L-amphetamine: equal cognitive enhancement, unequal MAO inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900405-4

7 January 2021

Monoamine oxidase inhibition by L-deprenyl depends on both sex and route of administration in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900405-4

7 January 2021

The effect of a long term (6 months) treatment with (-)deprenyl on antioxidant enzyme activities in selective brain regions in old female Fischer 344 rats

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900405-4

7 January 2021

Use of fluorescein hydrazide and fluorescein thiosemicarbazide reagents for the fluorometric determination of protein carbonyl groups and for the detection of oxidized protein on polyacrylamide gels

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900405-4

7 January 2021

Low selenium diet affects monoamine turnover differentially in substantia nigra and striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900405-4

7 January 2021

A rapid and sensitive assay for tyrosine-3-monooxygenase based upon the release of 3H2O and adsorption of [3H]-tyrosine by charcoal

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900405-4

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900405-4

7 January 2021

Determination of carbonyl groups in oxidatively modified proteins by reduction with tritiated sodium borohydride

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900405-4

7 January 2021

Role of type A and type B monoamine oxidase in the metabolism of released [3H]dopamine from rat striatal slices.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900405-4

7 January 2021

Increased tyrosine hydroxylase activity in central adrenaline neurons after reserpine treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900405-4

7 January 2021

Chronic cocaine administration increases CNS tyrosine hydroxylase enzyme activity and mRNA levels and tryptophan hydroxylase enzyme activity levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900405-4

7 January 2021

Differential effects of d-amphetamine, beta-phenylethylamine, cocaine and methylphenidate on the rate of dopamine synthesis in terminals of nigrostriatal and mesolimbic neurons and on the efflux of dopamine metabolites into cerebroventricular perfus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900405-4

7 January 2021

Pharmacological characterization of serotonin synthesis and uptake suggest a false transmitter role for serotonin in the pituitary intermediate lobe

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900405-4

7 January 2021

Dopamine turnover and glutathione oxidation: implications for Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900405-4

7 January 2021

Reactive oxygen species and the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900405-4

7 January 2021

Altered brain metabolism of iron as a cause of neurodegenerative diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900405-4

7 January 2021

Identification of catechol-protein conjugates in neostriatal slices incubated with [3H]dopamine: impact of ascorbic acid and glutathione

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900405-4

7 January 2021

Oxidative stress in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900405-4

7 January 2021

Antidepressants. A comparative review of the clinical pharmacology and therapeutic use of the 'newer' versus the 'older' drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900405-4

7 January 2021

10.1016/S0891-5849(96)00405-4

Identifiers

DOI

1 reference

3 June 2018

1 reference

3 June 2018